Improvement of Erectile Dysfunction by Fluvastatin in Patients With Cardiovascular Risk Factors
Status:
Withdrawn
Trial end date:
2007-12-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to determine the effect of fluvastatin on penile arterial blood
flow and erectile function in patients with arteriogenic ED and cardiovascular risk factors.